Available from: Bettge K, Kahle M, Abd El Aziz MS, Meier JJ, Nauck MA (2017) Occurrence of nausea, vomiting and diarrhoea reported as adverse events in clinical trials studying glucagon-like peptide-1 receptor agonists: A systematic analysis of published clinical trials
This is a bigger problem than most people realize
Medical supervision required
Obesity also has adverse occupation-related consequences (e.g., increased absences from work due to health issues and impaired work performance) [26]
This comparison therefore asks a focused question: does adding amylin receptor agonism to semaglutide meaningfully improve outcomes
Fake, adulterated, and misbranded products are prevalent in this market